Literature DB >> 21769015

Combat posttraumatic stress disorder, substance use disorders, and traumatic brain injury.

Kathleen T Brady1, Peter Tuerk, Sudie E Back, Michael E Saladin, Angela E Waldrop, Hugh Myrick.   

Abstract

Among both civilian and veteran populations, substance use disorders (SUDs) and anxiety disorders frequently co-occur. One of the most common comorbid anxiety disorder is posttraumatic stress disorder (PTSD), a condition which may develop after exposure to traumatic events, such as military combat. In comparison with the general population, rates of both SUDs and PTSD are elevated among veterans. Recent data show that soldiers returning from Iraq and Afghanistan demonstrate high rates of co-occurring SUDs, PTSD, and traumatic brain injury. Careful assessment of these conditions is critical and may be complicated by symptom overlap. More research targeting integrated interventions for these conditions is needed to establish optimal treatments.

Entities:  

Year:  2009        PMID: 21769015      PMCID: PMC4124907          DOI: 10.1097/ADM.0b013e3181aa244f

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  87 in total

1.  Neuropsychiatric consequences of traumatic brain injury: a review of recent findings.

Authors:  Ricardo E Jorge
Journal:  Curr Opin Psychiatry       Date:  2005-05       Impact factor: 4.741

Review 2.  The role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury patients.

Authors:  Shoumitro Deb; Tina Crownshaw
Journal:  Brain Inj       Date:  2004-01       Impact factor: 2.311

3.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

4.  Screening for PTSD in a substance abuse sample: psychometric properties of a modified version of the PTSD Symptom Scale Self-Report. Posttraumatic stress disorder.

Authors:  S F Coffey; B S Dansky; S A Falsetti; M E Saladin; K T Brady
Journal:  J Trauma Stress       Date:  1998-04

5.  Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.

Authors:  Kathleen T Brady; Susan Sonne; Raymond F Anton; Carrie L Randall; Sudie E Back; Kit Simpson
Journal:  Alcohol Clin Exp Res       Date:  2005-03       Impact factor: 3.455

Review 6.  Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder.

Authors:  S M Southwick; J D Bremner; A Rasmusson; C A Morgan; A Arnsten; D S Charney
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

7.  Fluoxetine versus placebo in posttraumatic stress disorder.

Authors:  Ferenc Martenyi; Eileen B Brown; Harry Zhang; Apurva Prakash; Stephanie C Koke
Journal:  J Clin Psychiatry       Date:  2002-03       Impact factor: 4.384

8.  Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs.

Authors:  R J Hawley; L F Major; E A Schulman; M Linnoila
Journal:  Arch Gen Psychiatry       Date:  1985-11

Review 9.  Buprenorphine: how to use it right.

Authors:  Rolley E Johnson; Eric C Strain; Leslie Amass
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

10.  New onset and persistent symptoms of post-traumatic stress disorder self reported after deployment and combat exposures: prospective population based US military cohort study.

Authors:  Tyler C Smith; Margaret A K Ryan; Deborah L Wingard; Donald J Slymen; James F Sallis; Donna Kritz-Silverstein
Journal:  BMJ       Date:  2008-01-15
View more
  8 in total

1.  The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.

Authors:  Daniel F Gros; Cynthia L Lancaster; Michael David Horner; Derek D Szafranski; Sudie E Back
Journal:  Compr Psychiatry       Date:  2017-07-17       Impact factor: 3.735

2.  Combat-Acquired Traumatic Brain Injury, Posttraumatic Stress Disorder, and Their Relative Associations With Postdeployment Binge Drinking.

Authors:  Rachel Sayko Adams; Mary Jo Larson; John D Corrigan; Grant A Ritter; Constance M Horgan; Robert M Bray; Thomas V Williams
Journal:  J Head Trauma Rehabil       Date:  2016 Jan-Feb       Impact factor: 2.710

3.  Alcohol Use after Combat-Acquired Traumatic Brain Injury: What We Know and Don't Know.

Authors:  Rachel Sayko Adams; John D Corrigan; Mary Jo Larson
Journal:  J Soc Work Pract Addict       Date:  2012-02-20

Review 4.  Alcohol Use Disorder and Traumatic Brain Injury.

Authors:  Zachary M Weil; John D Corrigan; Kate Karelina
Journal:  Alcohol Res       Date:  2018

5.  The Impact of Exercise and Virtual Reality Executive Function Training on Cognition Among Heavy Drinking Veterans With Traumatic Brain Injury: A Pilot Feasibility Study.

Authors:  David L Pennington; Jill V Reavis; Monique T Cano; Erica Walker; Steven L Batki
Journal:  Front Behav Neurosci       Date:  2022-03-22       Impact factor: 3.558

6.  Prevalence of Lifetime History of Traumatic Brain Injury among Older Male Veterans Compared with Civilians: A Nationally Representative Study.

Authors:  Erica S Kornblith; Kristine Yaffe; Kenneth M Langa; Raquel C Gardner
Journal:  J Neurotrauma       Date:  2020-08-26       Impact factor: 4.869

Review 7.  Updates and Current Perspectives of Psychiatric Assessments after Traumatic Brain Injury: A Systematic Review.

Authors:  Ana Luiza Zaninotto; Jessica Elias Vicentini; Felipe Fregni; Priscila Aparecida Rodrigues; Cibele Botelho; Mara Cristina Souza de Lucia; Wellingson Silva Paiva
Journal:  Front Psychiatry       Date:  2016-06-14       Impact factor: 4.157

8.  Current state of the literature on mental health in Liberia: A systematic review.

Authors:  Kimberly Hook; Kanako Ando; Senait Ghebrehiwet; Benjamin Harris; Babawale Ojediran; Haniya Syeda; David Henderson; Christina Borba
Journal:  S Afr J Psychiatr       Date:  2020-10-26       Impact factor: 1.550

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.